Navigation Links
Scientists Warn of New Multidrug-Resistant Salmonella
Date:8/3/2011

WEDNESDAY, Aug. 3 (HealthDay News) -- The identification of a new multidrug-resistant strain of salmonella shows the importance of public health surveillance in a global food system, French scientists say.

Their analysis of national surveillance systems in the United States, Denmark, France, England and Wales revealed the emergence of the S. Kentucky strain of salmonella, which has a high level of resistance to ciprofloxacin, a common treatment for severe salmonella infections.

This strain infected 489 patients in France, England and Wales, and Denmark between 2000 and 2008. The first infections were acquired mainly in Egypt between 2002 and 2005. Since 2006, infections have also been acquired in various parts of Africa and the Middle East.

About 10 percent of the European patients said they hadn't traveled to any of these areas, which suggests that their infections may have resulted from eating contaminated imported foods or through contact with infected people, said the Pasteur Institute researchers.

The investigators found that chickens and turkeys from Ethiopia, Morocco and Nigeria carried the S. Kentucky strain, an indication that poultry may be an important source of infection.

The study is published online in the Journal of Infectious Diseases.

"We hope that this publication might stir awareness among national and international health, food and agricultural authorities so that they take the necessary measures to control and stop the dissemination of this strain before it spreads globally, as did another multidrug-resistant strain of salmonella, Typhimurium DT104, starting in the 1990s," study co-leader Simon Le Hello said in a journal news release.

More information

The U.S. Centers for Disease Control and Prevention offers salmonella food safety tips.

-- Robert Preidt

SOURCE: The Journal of Infectious Diseases, news release, Aug. 3, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Johns Hopkins scientists begin first-of-its-kind research to create blood platelets from stem cells
2. Scientists show swamp gas protects blood vessels from complications of diabetes
3. Scientists receive funding boost to further research into disease mechanisms of Alzheimer’s
4. Scientists ID Gene Linked to Syndrome Behind Elephant Man Disease
5. Scientists developing new therapy for HER2-positive breast cancer
6. UT Southwestern scientists discover new pathway to potential therapies for advanced prostate cancer
7. Scientists Close in on Origins of Psoriasis, Eczema
8. Hebrew U. scientists identify molecular basis for DNA breakage
9. Scientists Spot Possible Target in Ovarian Cancer
10. 7 in 1 blow: Scientists discover DNA regions influencing prostate cancer risk
11. Gold nanoparticles bring scientists closer to a treatment for cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists Warn of New Multidrug-Resistant Salmonella
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, ... University of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) ... program, developed in association with efforts by the American College of Surgeons, U.S. ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... laboratory instruments are critical to ensuring high-quality results and maintaining GMP and USP ... of Laboratory Instruments in accordance with GMP requirements " these requirements are explained. ...
(Date:3/28/2017)... ... 28, 2017 , ... With less than 10,000 dermatologists in the United States ... be limited while the desire to conquer breakouts and eliminate skincare stress is widespread. ... customer online, today released its inaugural survey on the State of Acne in America. ...
(Date:3/28/2017)... ... , ... Columbus OH. Dr. Justin Harper, Founder of Juvly Aesthetics in Ohio ... country to sit on the 2017 National Advisory Board for Allergan’s Facial Aesthetics National ... helped propel the clinic from a small start-up to number 78 in the country ...
(Date:3/28/2017)... ... March 28, 2017 , ... Public relations pros work hard to ... of business channels. , While many results are clear, much of PR is hard ... , When it comes to measurement, firms should always take an all-inclusive approach that ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
(Date:3/28/2017)... , March 28, 2017 ... research with Cambridge ... Consortium   The Milner Therapeutics Institute today announces ... Elysium Health has committed significant investment for collaborative projects with ... next four years. This is the first major research investment ...
(Date:3/27/2017)... TEL-AVIV, Israel , March 27, 2017 /PRNewswire/ ... TASE: THXBY), a specialty clinical-stage pharmaceutical company specializing in the ... of its public offering in the ... Shares (ADSs), each ADS representing 40 ordinary shares ... per ADS. In addition, Therapix has granted the ...
Breaking Medicine Technology: